Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HIV Infections × X-Rays × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 21 Prostatic Neoplasms 20 Carcinoma, Non-Small-Cell Lung 14 Multiple Myeloma 12 Breast Neoplasms 12 Sarcoma 11 Glioma 10 Lymphoma, Non-Hodgkin 9 Wilms Tumor 8 Neuroblastoma 8 Leukemia, Myeloid, Acute 8 Rhabdoid Tumor 7 Ovarian Neoplasms 7 Osteosarcoma 7 Hepatoblastoma 7 Rhabdomyosarcoma 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Neoplasm Metastasis 6 Myelodysplastic Syndromes 6 Mouth Neoplasms 6 Medulloblastoma 6 Histiocytosis, Langerhans-Cell 6 Ependymoma 6 Colorectal Neoplasms 6 Carcinoma, Hepatocellular 6 Sarcoma, Ewing 5 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Neoplasms 5 Melanoma 5

Interventions

Doxorubicin 19 Vincristine 16 Cyclophosphamide 12 Zidovudine 11 Bleomycin 11 Etoposide 10 Rituximab 6 Interferon alpha-2 6 Cytarabine 6 Prednisone 5 Polymerase Chain Reaction 5 Liposomes 5 Dexamethasone 5 Biopsy 5 sargramostim 4 Specimen Handling 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Fluorouracil 4 Filgrastim 4 tecogalan 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Carmustine 3 interferon alfa-n1 2 fludarabine 2 cabozantinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡